Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children. - Wikidata - wikimedia - TriplyDB

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

http://www.wikidata.org/entity/Q37242216

about

Echinocandins in antifungal pharmacotherapy.

P2860

Q39458862-E875AD6F-B57D-4076-81A5-8D0E14BB2567

P2860

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

http://www.wikidata.org/entity/Q37242216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@en

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@nl

type

label

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@en

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@nl

prefLabel

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@en

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@nl

P1433

Q37242216-A651348C-DE2B-4EFD-ABAC-F2E2F872EF3D

P1476

Q37242216-9DA214B5-6E8A-4E3D-8F7F-B4A7C2A485D0

P2093

Q37242216-11256DCF-2D3E-4D9C-AAAC-12A4680E9EF0

Q37242216-12BD55CE-4C6F-495A-ACC0-0600C1367C10

Q37242216-3103D07E-744F-4E61-A4BF-56364B8045B9

Q37242216-482FDCEA-E307-4725-B3E3-57AD165114C6

Q37242216-86530786-19A6-43B0-B669-D14589655F7A

Q37242216-C4E03669-97D0-43BA-9B2C-B26819029D49

Q37242216-CEFDEF80-98EE-4B92-B589-525A94B120CF

Q37242216-D576C577-F4BF-498F-A0B8-DFC2053CA071

Q37242216-DA06C033-D04A-4386-8A64-36FF5D582EF1

Q37242216-FE31E491-C237-4A59-A937-7FA1AD232EF2

P2860

Q37242216-06AF7DE9-36C0-428A-BC3B-A48D05C2E03B

Q37242216-0940C76B-4E68-4DF1-9531-D0A21AB5B794

Q37242216-0E8A9C0D-4510-4938-8795-A1A1C9DBF574

Q37242216-137ECAA1-09CB-46E8-B6BB-F26C41689FE1

Q37242216-16B302B7-B4EC-47A6-94AF-BC52C6D303EC

Q37242216-1F22CA6E-3597-406C-B983-9918641A94EB

Q37242216-2010042C-74BF-43DC-97A0-92FD23910537

Q37242216-2691B267-B20E-4781-80CA-7A4D88025CB5

Q37242216-2DC305AA-0DB3-412C-A45C-7B7000488624

Q37242216-32024318-C225-418C-8173-DB974FBBFC99

P304

Q37242216-9B960EB7-6F8E-40F4-B6BC-FFFAE4309447

P31

Q37242216-A7475530-8155-4D49-8EEA-DB5EAD8F6505

P356

Q37242216-E77C2EE8-3070-4EA5-8412-83E00C57AC14

P433

Q37242216-1EA67062-4BA2-43C7-814A-0BE980FB5E7D

P478

Q37242216-A8F7464D-EA98-406A-B239-D53A087E3095

P50

Q37242216-BBDDAB07-572E-4716-93FF-CBC85BF7622A

P577

Q37242216-D9F47DB1-A092-4DAF-B807-F44E6E1E9220

P698

Q37242216-6CF30A2F-1D1F-4E4E-9D1C-9D1D6F7F37E8

P932

Q37242216-7D6F4F00-829C-4C7D-80E2-903B44B20B70

P356

P1433

Mediterranean journal of hematology and infectious diseases

P1476

Outcome of Candida Parapsilosis Complex Infections Treated with Caspofungin in Children.

@en

P2093

Ahu Kara

http://www.w3.org/2001/XMLSchema#string

Ferhat Sarı

http://www.w3.org/2001/XMLSchema#string

Gamze Gülfidan

http://www.w3.org/2001/XMLSchema#string

Gökhan Ceylan

http://www.w3.org/2001/XMLSchema#string

Hasan Ağın

http://www.w3.org/2001/XMLSchema#string

Mine Düzgöl

http://www.w3.org/2001/XMLSchema#string

Rana İşgüder

http://www.w3.org/2001/XMLSchema#string

Yüce Ayhan

http://www.w3.org/2001/XMLSchema#string

Özlem Sara Sandal

http://www.w3.org/2001/XMLSchema#string

İlker Devrim

http://www.w3.org/2001/XMLSchema#string

P2860

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobia

Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.

Real-world experience with echinocandin MICs against Candida species in a multicenter study of hospitals that routinely perform susceptibility testing of bloodstream isolates.

Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.

Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria.

Caspofungin susceptibility testing of isolates from patients with esophageal candidiasis or invasive candidiasis: relationship of MIC to treatment outcome

Candida parapsilosis, an emerging fungal pathogen

P304

e2016042

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4084/MJHID.2016.042

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27648205

http://www.w3.org/2001/XMLSchema#string

P932

5016015

http://www.w3.org/2001/XMLSchema#string